Many patients report symptoms during the first few weeks of treatment or immediately following a dose increase , when gastrointestinal side effects are most prominent and the body is adapting to the medication's metabolic effects
A growing body of evidence suggests that reactive oxygen species (ROS) are implicated in OA pathogenesis by triggering oxidative stress 2,8,9
The current guidelines recommended for acute heart failure (AHF) treatment still have some limitations such as the lack of consensus on the early management of HF decompensation
Production declines with age, and oral supplements absorb poorly (5-18%)
With varying dosing schedules, effectiveness, and additional mechanisms of action (like Mounjaros GIP activity), each medication offers unique advantages
They will advise you on what to do